DOLF Co-Founder and Co-Director Dr. Gary Weil receives the prestigious Kyelem Prize

We are pleased to share the news that DOLF Co-Director, Gary Weil received the 2023 Kyelem Prize at the annual Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD). Described by some as the “Oscar” of neglected tropical disease (NTD) research, this prize recognizes people in the field who have been particularly effective in bringing together the research community with those who implement NTD control and elimination programs.

Dr. Weil has been a leading researcher and contributor to the fields of filariasis and onchocerciasis for over 30 years. His research studying the effectiveness of IDA triple drug therapy for lymphatic filariasis (LF) elimination contributed to the World Health Organization’s policy recommendation to change standard drug regimens outside of Africa and albendazole monotherapy for LF elimination in Central Africa, resulting in improved health outcomes for millions. His research has, and continues to, contribute to the development of the antigen detection test for lymphatic filariasis (LF) a critical component for the global LF elimination program.

Many of his contributions to the field are outlined in his more than 200 publications – but also can be seen in the many relationships that he has formed in the NTD community. From his early work in Egypt to current studies examining improved treatments for LF and onchocerciasis in Indonesia and Liberia, Dr. Weil has formed long lasting relationships and partnerships with more than 30 organizations and over 15 mentees. Former Kyelem Prize awardee Julie Jacobson notes, “Gary is a friend and colleague that is very deserving of this award.  His work and continued contributions have made significant improvements in NTD programs and the lives of people around the world.”

You can read more about this award and Dr. Weils’ achievements here.

Gary Weil receives the prestigious Kyelem Prize at a special CORE-NTD ceremony in Chicago on October 17, 2023

Leave a Reply

Your email address will not be published. Required fields are marked *